So is our big day coming folks? Could it be one month away? The stars may be lining up or will it be like Waiting for Godot? I too am paying more attention to Zimmer and their activities. It is interesting that they got a downgrade today and their share price is languishing (like ours). Their shareholders must be demanding changes that will result in profitability. Dah!
I've been thinking about something boston posted a few weeks ago; that AMDA seems to have stockpiled their products and only has enough to last through Q2. Why is that? Why aren't they manufacturing more? In the light of having FDA approval recently, having added 14 sales reps last year, the hiring of a hot shot experienced sales management team (from Zimmer nonetheless), and having formed relationships with "several" medical groups last year. Isn't that what they announced in September? Seems strange doesn't it? Unless something REALLY BIG is up!
Then there's this quote from Sonny from the 1/25/18 press release of Amedica Provides Business Updates
"Strategic Direction
"Our strategic priorities are three-fold. The first priority is revenue growth, while controlling expenses, with the goal of financial self-sufficiency. Second, we will continue to investigate the full potential of silicon nitride ceramic and build collaborations with external partners. Third, while we consider ourselves to be a leader in the scientific knowledge of silicon nitride, the company is focused on building a strong portfolio of clinical evidence. Taken together, revenue growth, external collaborations, and clinical validation of our products are necessary to support product acceptance, and long-term sales growth," said B. Sonny Bal, MD, MBA, JD, PhD; Chairman and CEO of Amedica."
